Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

Mangoceuticals, Inc. Common Stock

Healthcare US MGRX

0.36USD
-0.0001(0.03%)

Last update at 2026-06-11T15:54:00Z

Day Range

0.360.37
LowHigh

52 Week Range

0.142.38
LowHigh

Fundamentals

  • Previous Close 0.36
  • Market Cap11.29M
  • Volume60335
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-9.01939M
  • Revenue TTM0.84M
  • Revenue Per Share TTM0.04
  • Gross Profit TTM 0.00485M
  • Diluted EPS TTM-0.44

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31
Type yearly yearly
Date 2022-12-31 2021-12-31
Income before tax -1.99805M -
Minority interest - -
Net income -1.99805M -
Selling general administrative 2.00M -
Selling and marketing expenses - -
Gross profit 0.00485M -
Reconciled depreciation 0.00386M -
Ebit -1.99158M -0.07008M
Ebitda -1.98772M -
Depreciation and amortization 0.00386M -
Non operating income net other - -
Operating income -1.99158M -
Other operating expenses 2.00M -
Interest expense 0.00647M -
Tax provision 0.00000M -
Interest income - -
Net interest income -0.00647M -
Extraordinary items - -
Non recurring - -
Other items - -
Income tax expense - -
Total revenue 0.00894M -
Total operating expenses 2.00M -
Cost of revenue 0.00409M -
Total other income expense net -0.00647M -
Discontinued operations - -
Net income from continuing ops -1.99805M -
Net income applicable to common shares -1.99805M -0.07080M
Preferred stock and other adjustments - -
Breakdown 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31
Total assets 1.05M 1.00M 0.02M
Intangible assets - - -
Earning assets - - -
Other current assets 0.06M - -
Total liab 0.28M 0.39M 0.04M
Total stockholder equity 0.77M 0.61M -0.01672M
Deferred long term liab - - -
Other current liab 0.00660M 0.00272M -
Common stock 0.00214M 0.00134M 0.00080M
Capital stock 0.00214M 0.00134M 0.00080M
Retained earnings -11.22817M -2.01576M -0.01770M
Other liab - - -
Good will - - -
Other assets - 0.02M -
Cash 0.74M 0.68M 0.02M
Cash and equivalents - - -
Total current liabilities 0.21M 0.26M 0.04M
Current deferred revenue - - -
Net debt -0.61033M -0.32999M 0.02M
Short term debt 0.06M 0.22M 0.04M
Short long term debt - 0.17M 0.04M
Short long term debt total 0.13M 0.35M 0.04M
Other stockholder equity 12.00M 2.63M 0.00018M
Property plant equipment - 0.29M -
Total current assets 0.82M 0.69M 0.02M
Long term investments - - -
Net tangible assets - 0.61M -0.01672M
Short term investments - - -
Net receivables 0.00000M - -
Long term debt - - -
Inventory 0.02M - -
Accounts payable 0.14M 0.03M -
Total permanent equity - - -
Noncontrolling interest in consolidated entity - - -
Temporary equity redeemable noncontrolling interests - - -
Accumulated other comprehensive income - - -
Additional paid in capital - - -
Common stock total equity - - -
Preferred stock total equity - - -
Retained earnings total equity - - -
Treasury stock - - -
Accumulated amortization - - -
Non currrent assets other 0.02M 0.02M -
Deferred long term asset charges - - -
Non current assets total 0.23M 0.31M 0.00000M
Capital lease obligations 0.13M 0.19M -
Long term debt total - - -
Breakdown 2022-12-31 2021-12-31
Type yearly yearly
Date 2022-12-31 2021-12-31
Investments -0.04310M -
Change to liabilities 0.03M 0.00000M
Total cashflows from investing activities -0.04310M -0.04310M
Net borrowings 0.05M 0.16M
Total cash from financing activities 2.05M 0.16M
Change to operating activities -0.01481M -0.01481M
Net income -1.99805M -0.07080M
Change in cash 0.66M 0.09M
Begin period cash flow 0.02M -
End period cash flow 0.68M 0.02M
Total cash from operating activities -1.34652M -0.07008M
Issuance of capital stock 2.00M -
Depreciation 0.00386M 0.00386M
Other cashflows from investing activities - -
Dividends paid - -
Change to inventory - -
Change to account receivables - -
Sale purchase of stock - -
Other cashflows from financing activities 0.07M -
Change to netincome 0.63M 0.00072M
Capital expenditures 0.04M 0.04M
Change receivables - -
Cash flows other operating - -
Exchange rate changes - -
Cash and cash equivalents changes - -
Change in working capital 0.02M -
Stock based compensation 0.23M -
Other non cash items 0.39M -
Free cash flow -1.38962M -

Peer Comparison

Sector: Healthcare Industry: Health Information Services

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
MGRX
Mangoceuticals, Inc. Common Stock		 -0.0001 0.03% 0.36 - - 8.15 7.70 7.32 -0.5829
VEEV
Veeva Systems Inc Class A		 -1.075 0.66% 162.69 54.61 33.22 12.83 6.73 11.14 58.84
MTHRF
M3 Inc		 - -% 8.55 29.72 25.00 0.05 4.38 0.04 0.12
MTHRY
M3 Inc		 -0.08 1.58% 4.98 31.84 26.25 0.05 4.60 0.04 0.12
BTSG
BrightSpring Health Services, Inc. Common Stock		 1.67 2.76% 62.26 100.22 40.65 0.69 4.92 0.92 25.80

Reports Covered

Stock Research & News

View All

Profile

Mangoceuticals, Inc. develops, markets, and sells various men's wellness products and services through a telemedicine platform in the United States. It offers erectile dysfunction (ED) products under the Mango brand and hair loss products under the Grow brand name. The company markets and sells these branded ED and hair loss products online through its website at MangoRx.com. Mangoceuticals, Inc. has a marketing agreement with Marius Pharmaceuticals, LLC to market and sell KYZATREX, an oral testosterone replacement therapy product under the PRIME program. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. is a subsidiary of Cohen Enterprises, Inc.

Mangoceuticals, Inc. Common Stock

15110 North Dallas Parkway, Dallas, TX, United States, 75248

Key Executives

Name Title Year Born
Mr. Jacob D. Cohen CEO & Chairman 1979
Mr. Eugene M. Johnston Chief Financial Officer 1964
Ms. Amanda Elizabeth Hammer Chief Operating Officer 1986

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions